Like many cancer therapies, ixazomib is associated with a range of side effects. Commonly reported adverse reactions include nausea, diarrhea, thrombocytopenia, peripheral neuropathy, and fatigue. It's crucial for healthcare providers to monitor patients closely and manage these side effects to maintain the quality of life during treatment.
